Welchol Articles
Impax Labs sued by Daiichi Sankyo and Genzyme after challenging Welchol patent in USA
18 January 2010
Negative press has compromised Vytorin as first-line therapy; DR
17 November 2008
Japan stock market week to Jan 28, 2008
4 February 2008
FDA approves Genzyme's Renvela
29 October 2007
Statins provide benefits after use stopped
22 October 2007
Daiichi Sankyo submits sNDA for WelChol
15 January 2007
Japan stock market week to Jan 8, 2007
15 January 2007
Japan stock market week to Sept 4, 2006
11 September 2006
Sankyo hits forecasts, R&D spending delayed
24 November 2003
4th-qtr charges hit Genzyme General
17 March 2003
Sankyo to launch Benicar in USA
6 May 2002
Japan pharma stocks: week to August 13
14 August 2001
Japan's Sankyo expanding in USA
23 January 2001
Healthy harvest of New Chemical Entities in 2000
2 January 2001
Genzyme Corp set to acquire GelTex Pharmaceuticals for $1 billion
12 September 2000
Stock Commentary Tokyo
8 June 2000
GelTex' Cholestagel lowers LDL-c, increases HDL-c
16 September 1999
GelTex files NDA for second product, Cholestagel
3 August 1999
Showing 1-22 of 22 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
